Status:
RECRUITING
A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suf...
Detailed Description
NOTE: Although Mayo Clinic in Arizona, Mayo Clinic in Florida, and Mayo Clinic in Rochester are the main study locations, this study is also recruiting (enrolling remotely) at the following Mayo Clini...
Eligibility Criteria
Inclusion
- A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site in the past 15 years
- Including malignant hematology
- Lymphoma
- Myeloma
- Chronic leukemias
- Age \>= 18
- Numeric Rating Scale (NRS) pain score of \>= 5/10
- Pain that developed or worsened following cancer diagnosis
- Fit the description of either rural or Hispanic or both
Exclusion
- Patient Health Questionnaire - 8 (PHQ8) score of \>= 13
- Hospice enrollment
- Skilled nursing facility, inpatient rehabilitation facility, or long-term care placement
- Encounters with Palliative Care or the Pain Clinic in the past two months or upcoming two months
- Any mention of hospice referral in medical oncology encounter notes (assess through textual search of the Mayo Data Explorer)
- Affirmative response to, "Are you usually confined to a bed or chair more than a third of your waking hours because of your health?"
- Currently homeless
- Do not feel safe in their home
- New or worsening chest pain, chest tightness, or chest pressure
- Back pain that is associated with a new or worsening weakness, control of bowels/bladder, or difficulty walking
- Lightheadedness, inability to keep down food or fluids, or vomiting blood or dark coffee-grounds-like material
- New or worsening headaches that are associated with vision changes, nausea, balance issues, or problems with speech
- Screens positive for use of non-cannabis drug use a a frequency of monthly or greater
- Inability to engage with the intervention due to medical or psychological response
Key Trial Info
Start Date :
February 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
660 Patients enrolled
Trial Details
Trial ID
NCT06198010
Start Date
February 7 2024
End Date
August 31 2027
Last Update
December 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
3
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905